Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Century Therapeutics (IPSC) Equity Ratio (2022 - 2025)

Historic Equity Ratio for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to 0.72.

  • Century Therapeutics' Equity Ratio rose 4310.95% to 0.72 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.72, marking a year-over-year increase of 4310.95%. This contributed to the annual value of 0.46 for FY2024, which is 1081.09% down from last year.
  • As of Q3 2025, Century Therapeutics' Equity Ratio stood at 0.72, which was up 4310.95% from 0.74 recorded in Q2 2025.
  • In the past 5 years, Century Therapeutics' Equity Ratio registered a high of 0.76 during Q1 2025, and its lowest value of 0.46 during Q4 2024.
  • Moreover, its 4-year median value for Equity Ratio was 0.61 (2023), whereas its average is 0.61.
  • As far as peak fluctuations go, Century Therapeutics' Equity Ratio crashed by 1768.02% in 2023, and later surged by 4925.63% in 2025.
  • Century Therapeutics' Equity Ratio (Quarter) stood at 0.62 in 2022, then fell by 17.68% to 0.51 in 2023, then dropped by 10.81% to 0.46 in 2024, then surged by 57.74% to 0.72 in 2025.
  • Its Equity Ratio stands at 0.72 for Q3 2025, versus 0.74 for Q2 2025 and 0.76 for Q1 2025.